{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:41:10Z","timestamp":1777354870120,"version":"3.51.4"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Myeloid sarcoma (MS) is a rare extramedullary manifestation of acute myeloid leukemia. While MS can involve various organs, isolated involvement of the nasal cavity or breast is uncommon, and the sequential involvement of both sites in a single patient is extremely rare. We present the case of a 68-year-old female who developed an MS relapse in the right breast 6\u202fyears after being treated for primary MS of the right nasal cavity. In 2018, she presented with a right nasal mass, initially suspected clinically to be a polyp. Histopathological and immunohistochemical (IHC) analyses confirmed MS. She achieved complete remission following localized radiotherapy and cytarabine-based systemic chemotherapy. After a six-year disease-free interval, she presented in 2025 with a painful right breast nodule. Initial imaging indicated a primary breast malignancy (BI-RADS 4B). However, postoperative IHC analysis, demonstrating myeloperoxidase (MPO) positivity, confirmed an extramedullary relapse of MS. The patient was subsequently treated with further chemotherapy and hypofractionated radiotherapy. This case highlights that extramedullary MS can perfectly mimic primary solid tumors both clinically and morphologically. It emphasizes the critical role of a comprehensive immunohistochemical panel, particularly the inclusion of myeloid-specific markers, in differentiating MS from poorly differentiated carcinomas. Such pathological vigilance is indispensable for avoiding catastrophic diagnostic pitfalls and preventing inappropriate surgical interventions in patients presenting with atypical extramedullary masses.<\/jats:p>","DOI":"10.3389\/fmed.2026.1822818","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:56:20Z","timestamp":1777352180000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Sequential nasal and mammary myeloid sarcoma with a 6-year latency: a case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiaxin","family":"Yu","sequence":"first","affiliation":[{"name":"School of Medicine, Shaoxing University","place":["Shaoxing, Zhejiang, China"]},{"name":"Department of General Surgery, Shaoxing People\u2019s Hospital","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanlin","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shaoxing People\u2019s Hospital","place":["Shaoxing, Zhejiang, China"]},{"name":"The First Affiliated Hospital of Shaoxing University","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Shaoxing People\u2019s Hospital","place":["Shaoxing, Zhejiang, China"]},{"name":"The First Affiliated Hospital of Shaoxing University","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.blre.2020.100773","article-title":"Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved","volume":"47","author":"Shallis","year":"2021","journal-title":"Blood Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemia"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.blre.2017.03.004","article-title":"The bone marrow microenvironment \u2013 home of the leukemic blasts","volume":"31","author":"Shafat","year":"2017","journal-title":"Blood Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e592","DOI":"10.1038\/bcj.2017.79","article-title":"Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set","volume":"7","author":"Goyal","year":"2017","journal-title":"Blood Cancer J"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1186\/s12885-019-6357-y","article-title":"Clinical and imaging features of myeloid sarcoma: a German multicenter study","volume":"19","author":"Meyer","year":"2019","journal-title":"BMC Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1016\/j.radcr.2022.09.003","article-title":"Breast manifestation of extramedullary myeloid sarcoma: a case report","volume":"17","author":"Naamo","year":"2022","journal-title":"Radiol Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/sj.leu.2402958","article-title":"Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy","volume":"17","author":"Tsimberidou","year":"2003","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1309\/AJCP1ZA7HYZKAZHS","article-title":"Myeloid Sarcoma","volume":"132","author":"Campidelli","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1751-553X.2011.01361.x","article-title":"State of the art in myeloid sarcoma: myeloid sarcoma","volume":"33","author":"Klco","year":"2011","journal-title":"Int J Lab Hematol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41586-019-1410-1","article-title":"Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion","volume":"572","author":"Paczulla","year":"2019","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5858\/2005-129-32-MSITB","article-title":"Myeloid sarcoma involving the breast","volume":"129","author":"Valbuena","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/2040620711410774","article-title":"Myeloid sarcoma: current approach and therapeutic options","volume":"2","author":"Avni","year":"2011","journal-title":"Therap Adv Hematol"},{"key":"ref15","first-page":"265","article-title":"Granulocytic sarcoma: a systematic review","volume":"3","author":"Yilmaz","year":"2013","journal-title":"Am J Blood Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid sarcoma: presentation, diagnosis, and treatment","volume":"17","author":"Almond","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1822818\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:56:20Z","timestamp":1777352180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1822818\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":16,"alternative-id":["10.3389\/fmed.2026.1822818"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1822818","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"article-number":"1822818"}}